Efficacy of Natural Herbal Formulation against Acute Hepatopancreatic Necrosis Disease (AHPND) causing Vibrio parahaemolyticus in Penaeus vannamei

Rajeev Kumar Jha*, Yousep Haig Babikian, Haig Yousep Babikian, Le Van Khoa, Daniel Wisoyo, Sarayut Srisombat and Benjamin Jiaravanon

Corresponding Author

Rajeev Kumar Jha, PhD

PT Central Proteina Prima, Indonesia, E-mail: Rajeev.kumar@cpp.co.id


Rajeev Kumar Jha, PhD1*; Yousep Haig Babikian, PhD1; Haig Yousep Babikian, MSc2; Le Van Khoa, PhD3; Daniel Wisoyo, BSc1; Sarayut Srisombat, MSc1; Benjamin Jiaravanon, MSc1

 1PT Central Proteina Prima, Indonesia

2Panacea Natural Sciences, Indonesia

3Department of Agriculture and Rural Development, Vietnam

Corresponding Author

Rajeev Kumar Jha, PhD

PT Central Proteina Prima, Indonesia, E-mail: Rajeev.kumar@cpp.co.id

Article History

Received: October 17th, 2016 , Accepted: November 3rd, 2016  , Published: November 3rd, 2016

Cite this Article

Jha RK, Babikian YH, Babikian HY, et al. Efficacy of natural herbal formulation against acute hepatopancreatic necrosis disease (AHPND) causing Vibrio parahaemolyticus  in penaeus vannamei. Vet Med Open J. 2016; 2(1): 1-6. doi: 10.17140/VMOJ-2-109


©2016 Jha RK. This is an open access article distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.



A formulation was developed using combination of blended natural essential oils as an anti-Vibrio parahemolyticus causing acute hepatopancreatic necrosis disease (AHPND) candidate. Lavandula latifolia, Pinus sylvestris, Jasminum officinale, Citrus limon, Prunus avium, Viola odorata, Gardenia jasminoides, Cocos nucifera, Rosa damascene and Eucalyptus globulus, mixed together to develop as anti-V. parahemolyticus product. The treatment group was fed on essential oil mixed feed whereas control group were fed on the regular feed throughout the experiment.  The shrimp of both treatment and control were challenged by immersion method at day 8. The cumulative AHPND-gross sign appearance in positive control reached up to 95% at dpi 10 whereas no gross sign appeared in treatment and in negative control. The cumulative mortality reached up to 46.7% at dpi 10 in positive controls whereas no mortality recorded in treatment and in negative control. The V. parahaemolyticus isolated from the hepatopancreas of infected shrimp matched 100% with the existing AHPND strain. The trial results show that the developed natural herbal formulation has significant effect against AHPND in a controlled condition.

ABBREVIATIONS: AHPND: Acute Hepatopancreatic Necrosis Disease; SPF: Specific Pathogen Free; DO: Dissolved Oxygen; WSSV: White Spot Syndrome Virus; IMNV: Infectious Myonecrosis Virus; IHHNV: Infectious Hypodermal and Haematopoietic Necrosis Virus; TSV: Taura Syndrome Virus; YHV: Yellow Head Virus; PCR: Polymerase Chain Reaction; BLAST: Basic Local Alignment Search Tool.


The acute hepatopancreatic necrosis disease (AHPND) has affected shrimp farming in several countries, like, Vietnam, Malaysia, Thailand, Mexico and in Philipines.1,2,3,4,5,6 The unique symptoms and characteristics of this disease consisting of massive sloughing of hepatopancreas epithelial cells.4 The external symptoms in infected shrimp like, empty stomach, bluish body color and shrunken hepatopancreas could be observed. The rate of mortality is significantly higher on the 1st 3 days of infection. The AHPND appear in the culture ponds from 8-45 days of stocking.

The Vibrio parahaemolyticus was identified as causative agent of AHPND by Tran et al.7 It carries a plasmid (pAP1) of approximately 69 kbp. This plasmid contains 2 genes which produce toxins. These 2 genes act together to cause AHPND in shrimp. The susceptible known species are Penaeus vannamei, P. monodon and P. chinensis.8

There are several efforts done to minimize the effect of pathogen using herbal products. Other authors9 showed the antimicrobial effects of 2 essential oils (EOs) Vibrio concentrations in the rearing water of Penaeus monodon.

The proposed trial was designed with the objective to determine the efficacy of essential oil enriched shrimp feed against Vibrio parahemolyticus in Penaeus vannamei.


Bioassay Lab and Glass Aquaria

A bioassay trial was set-up using 6 aquaria each for experimental groups as well as for control groups. The specific pathogen free (SPF) juvenile shrimp 10 each in number were maintained in 6 aquaria each. Each aquarium was filled with 5 litre of seawater provided with required dissolved oxygen (DO) supply.

Location and Time Period

The experiment was conducted in bio-secured laboratories at Ben Tre Aquaculture Station, Binh Dai, and Extension Department, Vietnam in the period of September 16, 2014 to October 30, 2014.

Experimental Shrimp

Shrimp of mean body weight 0.23 to 0.33 g were used to conduct the trial. The available size of SPF Shrimp (PL 10) were procured from a bio-secured Hatchery (Ca Dec Seed Production Centre, Ben Tre, Vietnam) and reared in 500-litre capacity tank for 10-15 days.

Shrimp Screening and Acclimatization

The shrimp were screened at Government disease diagnostic center (RAHO), Ho Chi Minh City and CÔNG TY CO PHAN DICH VU THUY SAN THANH LOAN Disease Diagnosis Lab at Ho Chi Minh City for pathogen of shrimp i.e. white spot syndrome virus (WSSV), Infectious myonecrosis virus (IMNV), infectious hypodermal and haematopoietic necrosis virus (IHHNV), taura syndrome virus (TSV), yellow head virus (YHV) and Vibrio spp. prior to start of the trial.

Shrimp Food

Shrimp feed were produced at Feedmill, Lampung of PT. Central Proteinaprima Tbk. The feed types were as followed, post-larvae feed (PL 03:250-400 micron) and shrimp feed (CP 001:0.425-0.75 mm and CP 02:0.71-1 mm) as per the requirement of experimental shrimp. The anti-AHPND essential oil formulation were developed by combining the essential oil blend extracted from the following 10 plants, Lavandula latifolia, Pinus sylvestris, Jasminum officinale, Citrus limon, Prunus avium, Viola odorata, Gardenia jasminoides, Cocos nucifera, Rosa damascene and Eucalyptus globulus. Using expeller-pressing method (Anderson International Corp, OH, USA) performed the oil extractions from the selected plants.10 The essential oil blend were mixed with the feed in required amount. The basic formulation of both the feed was same except essential oil mixed in the experimental feed.

AHPND Disease Challenge Procedure

The immersion method of challenge was applied in the trial.11 The isolated purified bacteria, Vibrio parahemolyticus, strain VP A/3 (procured in August 2014 from University of Arizona, USA) were utilized for the trial. The V. parahemolyticus was grown up to the density of 107 CFU/ml in Tryptose Soy Broth (TSB) and then 5 ml of it was poured in each tank. The final V. parahemolyticus concentration in the tank water was 105 CFU/ml. The 5 ml blank TSB was applied in the negative control tanks (Table 1).


Table 1: Experimental design of immersion challenge trial.


Replicate MBW (gr) Density/5 L Bacteria Density


Challenge methods Feed Water Exchange
Positive Control 6 0.23-0.33 5 107 Pour 5 mL of Vibrio
in each tank

20%/ day (no water exchange during challenge)


Essential oil enriched

Negative Control

Pour 5 mL of sterile TSB
solution in each tank



Post-Challenge Observation

EMS gross sign observation: The challenged shrimp were observed for body color, hepatopancreas color and shape and feed consumption rate and cumulative mortality. The severity level of infection was categorized into:

  • Medium level G2: Hepatopancreas color light pale, yellow within hepatopancreas connective tissue capsule, size of hepatopancreas normal and no sign of atrophy;
  • Severe level G3: Hepatopancreas color pale, yellow or white within hepatopancreas connective tissue capsule, significant sign of atrophy in hepatopancreas (shrunken).

Lab confirmation: The AHPND was confirmed by typical gross sign appearance, by polymerase chain reaction (PCR) analysis and sequencing analysis.

Vibrio parahaemolyticus Isolation and Sequencing Analysis

The Vibrio parahaemolyticus was isolated from the hepatopancreas of challenged shrimp using Chrom-Vibrio agar. The colonies of V. parahaemolyticus spp. appeared mauve color. Further, sequencing of obtained V. parahaemolyticus was carried out. The primers utilized were AP3 Reverse and AP3 Forward12 with a base length of 236 bp. The analysis of sequencing was performed at First Base, Singapore.

Statistical analysis: Statistical analysis were done by analysis of variance (ANOVA) with p<0.05 confidence level.


Shrimp Gross Sign Appearance

The positive control shrimp started showing the clear symptoms of AHPND after 18 to 22 hour of challenge. The stomach was empty and significant drop in the lipid droplets in hepatopancreas.

Feeding Rate

The feed consumption dropped significantly after challenge in positive control (about 50%).  It showed the stress in shrimp. The shrimp start recovering in the treatment group from dpi 3 onwards (Figure 1).

Figure 1: Daily feed consumption rate in percentage (%).

VMOJ-2-109 Fig 1


Cumulative Mortality

The cumulative gross sign appearance in positive control reached up to 56% by day 3 of challenge (Figure 2). The typical gross sign of AHPND, like, shrinkage of hepatopancreas, reduction in lipid content and empty stomach, started appearing from the day of challenge. The cumulative mortality rate was 46.7% at dpi 10 after challenge in positive control whereas no mortality in treatment group and in the negative control group (Figure 3). The moribund and dead shrimp had clear symptoms of AHPND.

Figure 2: Cumulative gross sign percentage of AHPND in trial groups.

VMOJ-2-109 Fig 2


Vibrio parahaemolyticus Isolation and Basic Local Alignment Search Tool (BLAST) and Sequence Alignment

The extracted Vibrio parahaemolyticus from the stomach of positive control shrimp were sequenced (Table 2) and aligned (Figure 4).


Figure 4: Result of BLAST and alignment analysis.

VMOJ-2-109 Fig 4


Table 2: Sequences producing significant alignment National Center for Biotechnology Information (NCBI) blast.


Max Score Total Score Query Cover E value Ident


Vibrio parahaemolyticus strain 3 HP plasmid pVA1, complete sequence


425 99% 2e-115 100%


Vibrio parahaemolyticus genes for hypothetical proteins, JHE-like toxin PirA-like, JHE-like toxin PirB-like, complete cds


425 99% 2e-115 100%


Vibrio parahaemolyticus strain 13-028/A3 plasmid pVPA3-1, complete sequence


425 99% 2e-115 100%


Vibrio parahaemolyticus strain 20130629002S01 putative VP19 protein (vp19) gene, complete cds


425 99% 2e-115 100%


Vibrio parahaemolyticus plasmid pVPA3-1 DNA, putative toxin region


348 84% 3e-92 99%


The results of BLAST and alignment analysis from National Center for Biotechnology Information (NCBI) showed that the sample was identical to accession number KM067908.1 (Figure 3) that is Vibrio parahaemolyticus 13-028/A3 and 13-028/A2. Strain 13-028/A3 was determined to cause this disease through laboratory bioassays (Table 3).7

Figure 3: Cumulative mortality percentage of trial groups.

VMOJ-2-109 Fig 3


Table 3: Statistical analysis of AHPND challanged treatment and control groups using ANOVA


Subset for alpha=.05


N 1 2
Treatment Feed Group

Negative Control Group

Positive Control Group











Means for groups in homogeneous subset are displayed. aUses Harmoni Mean Sample Size = 6.000.

Statistical Analysis

There was significant difference between treatment and positive control in terms of cumulative mortality.


The AHPND has appeared in almost all major shrimp producing countries of South East Asia. Much effort has been made to minimize the effect of disease by application of various available products like, probiotics, bacteriophages, immunostimulants, herbal extracts, quorum quenching, acidifiers and toxin absorbents, etc., with potential of anti-AHPND properties. However, most of them could not achieve the successful outcome as per expectation. The combinations of 10 natural oils were formulated to develop as anti-AHPND in the present study. The selection of oil for the formulation was done on the basis of their anti-viral and anti-bacterial properties. The product is combination of blend essential oils. The artificial feed as a carrier of anti-AHPND product is one of the best ways to provide the protection to the shrimp. Vietnam is one of the major suffering countries due to AHPND and so was selected for the trial site.

The final laboratory results provide conclusive evidence that in a controlled environment anti-AHPND feed provide prevention against AHPND-Vibrio parahemolyticus. The treatment shrimp that ingested AHPND infected tissue did not develop AHPND and did not show gross signs and no mortality during the experimental period. However, in contrast the shrimps in the positive control group demonstrated up to 46.7% mortality with clear symptoms of AHPND. The AHPND gross-sign appearance in the challenged shrimp was similar and as described by NACA, OIE, Tran et al.13,14,7 There was feed drop on first 3 days of challenge in positive control, which indicates that the digestive system of the challenged animals without protection was damaged. The immersion method of challenge using purified and certified pathogenic Vibrio parahemolyticus procured from University of Arizona was selected to avoid any risk of contamination. The rate of mortality in the challenged group was similar to the field reports i.e. heavy mortality for 3 to 5 days with significant drop in feed intake. The bioassay challenge trial conducted by Tran et al7 received the similar rate of mortality as recorded in the positive control of the current trial. The Vibrio parahemolyticus has short generation time which facilitates colonization and result of which large number of cells can dominate the host in a short period of time, giving it advantage to dominate over other bacteria in the surrounding environment.8,15

The sequencing alignment analysis results showed that the isolated V. parahemolyticus causing typical symptoms of AHPND is 100% matching with the strain isolated by Tran et al and Lightner DV.7,16 The core genome of all V. parahemolyticus strains is composed of 3,284 genes, 24.3% of total pangenome. The core genome of only the pathogenic strains has 3,358 genes (FAO 2016).8 Whereas, there are possibilities of more than one strain of V. parahemolyticus or isolates of other Vibrio species carrying the pathogenic genes (PIR A and PIR B) to cause symptoms like AHPND in shrimp.8,17,18


The obtained results and the analysis shows that the shrimp fed on blended oil mixed with feed have significant protection against AHPND-Vibrio parahemolyticus. The next step would be to conduct field trials in culture ponds to determine the efficacy of developed feed against AHPND.


We would like to thank PT. Central Proteina Prima, Indonesia and Panacea Natural Sciences, Indonesia to provide funding for the research. We thank Directorate of Fisheries, Government of Vietnam, providing facilities, guidance and special assistance in conducting the bioassay trial. We also would like to thank Prof. Don Lightner, University of Arizona, USA for providing the AHPND strain of Vibrio parahemolyticus.


The authors declare that they have no conflicts of interest.

1. FAO. FAO/MARD Technical Workshop on Early Mortality Syndrome (EMS) or Acute Hepatopancreatic Necrosis Syndrome (AHPNS) of Cultured Shrimp (under TCP/VIE/3304). 2013. FAO Fisheries and Aquaculture Report No. 1053. Rome. 54.

2. Flegal TW. Historic emergence, impact and current status of of shrimp pathogens in Asia. J Invertebr Pathol. 2012; 110: 166-173. doi: 10.1016/j.jip.2012.03.004

3. Leaño EM, Mohan CV. Early Mortality Syndrome threatens Asia’s shrimp farms. Global Aquaculture advocate. 2012. 38-39. Web site. https://www.gaalliance.org/mag/2012/Jul-Aug/download.pdf. Accessed August 1, 2016.

4. Lightner D, Redman VR, Pentoja C, Noble B, Tran L. Early mortality syndrome affects shrimp in Asia. Global Aquaculture Advocate. 2012; 15-20. Web site. http://pdf.gaalliance.org/pdf/GAA-Lightner-Jan12.pdf. Accessed August 1, 2016.

5. Mooney A. An emerging shrimp disease in Vietnam, microsporidiosis or liver disease? 2012.

6. Nunan L, Lightner D, Pantoja C, Gomez-Jinenez S. Detection of acute hepatopancreatic necrosis disease (AHPND) in Mexico. Dis Aquat Organ. 2014; 111: 81-86. doi: 10.3354/dao02776

7. Tran L, Nunan L, Redman RM, et al. Determination of the infectious nature of the agent of acute hepatopancreatic necrosis syndrome affecting penaeid shrimp. Dis Aquat Org. 2013; 105: 45-55. doi: 10.3354/dao02621

8. FAO. 2016. FAO Second International Technical Seminar/Workshop on Acute Hepatopancreatic Necrosis Disease (AHPND) There is a way forward! FAO Technical Cooperation Programme: TCP/INT/3501 and TCP/INT/3502. 1-92.

9. Sarter S, Randrianarivelo R, Ruez P, Raherimandimby M, Danthu P.  Antimicrobial effects of essential oils of Cinnamosma fragrans on the bacterial communities in the rearing water of Penaeus monodon larvae. Vector-Borne and Zoonotic Diseases. 2011; 11(4): 433-437. doi: 10.1089/vbz.2010.0069

10. Anderson G. Oil Seed Production. 2004. Pub. No. US 20040013790A1.

11. Saulnier D, Haffner P, Goarant C, Levy P, Ansquer D. Experimental infection models for shrimp vibriosis studies: A review. Aquaculture. 2000; 191: 133-144. doi: 10.1016/S0044-8486(00)00423-3

12. Sirikharin R, Taengchaiyaphum S, Sritunyalucksana K, et al. A new and improved PCR method for detection of AHPND bacteria. 2014. Web site. http://www.enaca.org/modules/news/article.php?article_id=2030. Accessed August 1, 2016

13. NACA. Disease card: Diseases of crustaceans – Acute hepatopancreatic necrosis syndrome. 2012. Web site. http://library.enaca.org/Health/DiseaseLibrary/ahpns-disease-card.pdf. Accessed August 1, 2016.

14. OIE. Technical Disease Cards: Acute Hepatopancreaticnecrosis syndrome. 2013. Web site. http://www.enaca.org/publications/health/disease-cards/ahpns-disease-advisory-update-march-2013.pdf. Accessed August 1, 2016.

15. Han JE, Mohney LL, Tang KFJ, Pantoja CR, Lightner DV. Plasmid mediated tetracycline resistance of Vibrio parahaemolyticus associated with acute hepatopancreatic necrosis disease (AHPND) in shrimps. Aquaculture Reports. 2015; 2: 17-21. doi: 10.1016/j.aqrep.2015.04.003

16. Lightner DV. Documentation of a unique strain of Vibrio parahemolyticus as the agent of Early Mortality Syndrom (EMS) or acute hepatopancreatic necrosis disease (AHPND) affecting Penaeid shrimp with notes on the putative toxins. 9th symposium on Disease in Asian Aquaculture; Ho Chi Minh City, Vietnam. 2014.

17. Flegel T, Lo CF. Primers for specific detection of bacterial isolates that cause acute hepatopancreatic necrosis disease (AHPND). 2014 Web site. http://www.enaca.org/publications/health/disease-cards/ahpnd-detection-method-announcement.pdf. Accessed August, 1, 2016.

18. Joshi J, Srisala J, Truong VH, et al. Variation in Vibrio parahaemolyticus isolates from a single Thai shrimp farm experiencing an outbreak of acute hepatopancreatic necrosis disease (AHPND). Aquaculture. 2014; 428: 297-302. doi: 10.1016/j.aquaculture.2014.03.030


Laparoscopic Management of Adrenal and Extra-Adrenal

Laparoscopic Management of Adrenal and Extra-Adrenal Pheochromocytoma

Shrenik J. Shah*, Sajid Nurbhai, Rusha Surti, Parixit Malaviya and Pratik Chaudhary


Penile Cancer in the Region of Thies

Penile Cancer in the Region of Thies: Epidemiological, Diagnostic and Therapeutic Aspects

Saint C. N. Kouka*, Tonleu L. Bentefouet, Ngor M. Thiam, Modou Faye, Mbayang Diop, Mouhamed Cisse, Mohamed Jalloh, Aissatou A. Diame, Yoro Diallo and Sylla Cheikhna


Coronavirus Disease-2019 Infection-Associated Glomerular Diseases

Phuong-Chi T. Pham*, Golriz Jafari, Anita Kamarzarian, Vinod K. Valluri, Kulwant Bath, Chau Sally, Nguyen Tuan, Mahalli Joseph, Phuong-Mai T. Pham, Phuong-Anh T. Pham, Son V. Pham and Phuong-Thu T. Pham


West Virginia University Medicine, Wheeling Hospital’s Sepsis Study

Ramya Ramesh*, Jazmin Jatana, Chan Hong, Sathyanarayana Machani, Milind Awale, Stanley Guertal, Catherine Macalister, Heather L. Merkel, Melissa Burkett and Silvia Myndresku

doi. 10.17140/EMOJ-10-173

Yet Another Public Health Threat: A Commentary and Examination of the Extensive Use of Bromazolam

Nelson J. Tiburcio* and Scarlett L. Baker